Eli Lilly & Co., headquartered in Indianapolis, employs 43,000 staff and develops various pharmaceutical products, including diabetes, oncology, immunology, and neuroscience therapies, alongside radiopharmaceuticals through its subsidiary POINT Biopharma. The company manufactures and distributes products in the U.S., Europe, and Asia.
LLY has been in the news recently: Eli Lilly and Company has announced its acquisition of Verve Therapeutics for up to $1.3 billion, which will enhance its pipeline of treatments for cardiovascular disease. This acquisition follows recent deals totaling $3.5 billion, positioning Eli Lilly as a strong player in the gene-editing sector.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
